Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation

Por Funakoshi-Tago, Megumi, Yu, Seisho, Kushida, Akira, Takeuchi, Kazusane, Tamura, Hiroomi
Publicado no Heliyon (2020)

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

Por Suga, Takayoshi, Kikuchi, Osamu, Kobayashi, Masaki, Matsui, Sho, Yokota-Hashimoto, Hiromi, Wada, Eri, Kohno, Daisuke, Sasaki, Tsutomu, Takeuchi, Kazusane, Kakizaki, Satoru, Yamada, Masanobu, Kitamura, Tadahiro
Publicado no Mol Metab (2018)